About the Authors
- Drew C. Deniger
-
Current address: Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America
Affiliations Pediatrics, Children’s Cancer Hospital, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, United States of America
- Jianqiang Yu
-
Affiliation Medicine, Moores Cancer Center, University of California San Diego, San Diego, California, United States of America
- M. Helen Huls
-
Affiliation Pediatrics, Children’s Cancer Hospital, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
- Matthew J. Figliola
-
Affiliation Pediatrics, Children’s Cancer Hospital, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
- Tiejuan Mi
-
Affiliation Pediatrics, Children’s Cancer Hospital, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
- Sourindra N. Maiti
-
Affiliation Pediatrics, Children’s Cancer Hospital, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
- George F. Widhopf 2nd
-
Affiliation Medicine, Moores Cancer Center, University of California San Diego, San Diego, California, United States of America
- Lenka V. Hurton
-
Affiliations Pediatrics, Children’s Cancer Hospital, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, United States of America
- Radhika Thokala
-
Affiliations Pediatrics, Children’s Cancer Hospital, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, United States of America
- Harjeet Singh
-
Affiliation Pediatrics, Children’s Cancer Hospital, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
- Simon Olivares
-
Affiliation Pediatrics, Children’s Cancer Hospital, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
- Richard E. Champlin
-
Affiliation Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
- William G. Wierda
-
Affiliation Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
- Thomas J. Kipps
-
Affiliation Medicine, Moores Cancer Center, University of California San Diego, San Diego, California, United States of America
- Laurence J. N. Cooper
-
* E-mail: ljncooper@mdanderson.org
Affiliations Pediatrics, Children’s Cancer Hospital, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas, United States of America
Competing Interests
Dr. Cooper founded and owns InCellerate, Inc. He has patents with Sangamo BioSciences with artificial nucleases. He consults with Targazyme, Inc. (formerly American Stem cells, Inc.), GE Healthcare, Ferring Pharmaceuticals, Fate Therapeutics, Janssen Pharmaceuticals, and Bristol-Myers Squibb. He is on the Scientific Advisory Board of Cellectis. He receives honoraria from Miltenyi Biotec. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: DCD REC WGW TJK LJNC. Performed the experiments: DCD JY MHH MJF TM SNM GFW RT. Analyzed the data: DCD MHH MJF TM JY GFW. Contributed reagents/materials/analysis tools: DCD JY LVH GFW HS SO WGW TJK. Wrote the paper: DCD WGW TKJ LJNC.